Silvana Capalbo

1.4k total citations
37 papers, 669 citations indexed

About

Silvana Capalbo is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Silvana Capalbo has authored 37 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Hematology and 10 papers in Oncology. Recurrent topics in Silvana Capalbo's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (7 papers). Silvana Capalbo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (7 papers). Silvana Capalbo collaborates with scholars based in Italy, Germany and Japan. Silvana Capalbo's co-authors include Vincenzo Liso, Giorgina Specchia, Arcangelo Liso, Felicetto Ferrara, Catello Califano, Luca Laurenti, Giovanni D’Arena, Nicola Cascavilla, Antonio Pinto and Nicola Di Renzo and has published in prestigious journals such as Blood, British Journal of Haematology and Clinical Microbiology and Infection.

In The Last Decade

Silvana Capalbo

36 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Capalbo Italy 15 289 271 179 166 144 37 669
Takuya Komeno Japan 13 278 1.0× 166 0.6× 175 1.0× 114 0.7× 144 1.0× 49 595
Dina Attias Israel 16 205 0.7× 215 0.8× 210 1.2× 218 1.3× 169 1.2× 46 864
Maurizio Longinotti Italy 15 388 1.3× 315 1.2× 189 1.1× 93 0.6× 139 1.0× 65 707
Gianluigi Castoldi Italy 19 483 1.7× 278 1.0× 330 1.8× 252 1.5× 237 1.6× 36 957
Anastasia Athanasiadou Greece 16 203 0.7× 314 1.2× 205 1.1× 103 0.6× 141 1.0× 45 604
Vassiliki Pappa Greece 15 169 0.6× 193 0.7× 132 0.7× 223 1.3× 204 1.4× 48 736
Mordechai Shtalrid Israel 15 488 1.7× 412 1.5× 178 1.0× 130 0.8× 114 0.8× 36 851
Kirsten Herbert Australia 14 271 0.9× 154 0.6× 128 0.7× 210 1.3× 82 0.6× 26 684
Mineo Kurokawa Japan 10 387 1.3× 177 0.7× 131 0.7× 99 0.6× 304 2.1× 24 728
Rose Beck United States 14 172 0.6× 122 0.5× 266 1.5× 262 1.6× 149 1.0× 49 699

Countries citing papers authored by Silvana Capalbo

Since Specialization
Citations

This map shows the geographic impact of Silvana Capalbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Capalbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Capalbo more than expected).

Fields of papers citing papers by Silvana Capalbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Capalbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Capalbo. The network helps show where Silvana Capalbo may publish in the future.

Co-authorship network of co-authors of Silvana Capalbo

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Capalbo. A scholar is included among the top collaborators of Silvana Capalbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Capalbo. Silvana Capalbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavone, Vincenzo, Anna Mele, Giorgina Specchia, et al.. (2018). Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP). Annals of Hematology. 97(10). 1817–1824. 6 indexed citations
2.
Graffigna, Guendalina, Massimo Breccia, Enrico Capochiani, et al.. (2017). Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine. Quality of Life Research. 26(10). 2739–2754. 20 indexed citations
3.
Mazza, Patrizio, Giorgina Specchia, Nicola Di Renzo, et al.. (2016). Ruxolitinib – better prognostic impact in low-intermediate 1 risk score: evaluation of the ‘rete ematologica pugliese’ (REP) in primary and secondary myelofibrosis. Leukemia & lymphoma. 58(1). 138–144. 5 indexed citations
4.
Delia, Mario, Paola Carluccio, Caterina Buquicchio, et al.. (2015). Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP). Leukemia Research. 39(11). 1166–1171. 4 indexed citations
5.
6.
7.
Molica, Stefano, Maura Brugiatelli, Fortunato Morabito, et al.. (2013). Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need. Expert Review of Hematology. 6(4). 441–449. 7 indexed citations
8.
Nosari, A., Morena Caira, Rosa Fanci, et al.. (2012). Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections. Clinical Microbiology and Infection. 19(8). 757–762. 25 indexed citations
9.
Olíva, Esther Natalie, Francesco Albano, Nicola Di Renzo, et al.. (2012). Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy. Blood. 120(21). 5200–5200. 1 indexed citations
10.
Ieva, Riccardo, et al.. (2009). An Extramedullary Lesion in Multiple Myeloma: Voluminous Pericardial Mass. Clinical Cardiology. 32(8). E73–E73. 4 indexed citations
11.
Capalbo, Silvana, et al.. (2006). Jaw Osteonecrosis Associated with Use of Bisphosphonates and Chemotherapy: Paradoxical Complication of Treatment of Bone Lesions in Multiple Myeloma Patients. International Journal of Hematology. 83(5). 439–442. 15 indexed citations
12.
Capalbo, Silvana, Vincenzo Callea, Caterina Musolino, et al.. (2004). Familial B-Cell Chronic Lymphocytic Leukemia in a Population of Patients from Southern Italy. International Journal of Hematology. 79(4). 354–357. 6 indexed citations
13.
Capalbo, Silvana, et al.. (2003). Mycosis Fungoides/Sézary Syndrome: A Report of Three Cases Treated with Campath-1H as Salvage Treatment. Medical Oncology. 20(4). 389–396. 15 indexed citations
14.
Specchia, Giorgina, Francesco Albano, Luisa Anelli, et al.. (2002). Concomitant tetrasomy 3q and trisomy 18 in CD5−, CD13+ chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 133(2). 160–163. 7 indexed citations
15.
Capalbo, Silvana, et al.. (2000). Increased risk of lymphoproliferative disorders in relatives of patients withB‐cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. European Journal Of Haematology. 65(2). 114–117. 31 indexed citations
16.
Liso, Vincenzo, et al.. (1995). Cytophagocytosis by the Blast Cells in Acute Myeloid Leukemia. Leukemia & lymphoma. 18(sup1). 65–68. 9 indexed citations
17.
Specchia, Giorgina, Maria Teresa Montagna, Silvana Capalbo, et al.. (1994). INCIDENZA DELLE INFEZIONI MICOTICHE IN PAZIENTI CON NEUTROPENIA SEVERA. Haematologica. 79(79). 138–140. 1 indexed citations
18.
Tosi, Sabrina, Stephan Stilgenbauer, Giovanni De Giudici, et al.. (1994). Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: Report and cytogenetic analysis of two cases. Cancer Genetics and Cytogenetics. 77(2). 106–110. 15 indexed citations
19.
Specchia, Giorgina, Vincenzo Liso, Silvana Capalbo, et al.. (1992). Constitutive expression of IL‐1β, M‐CSF and c‐fms during the myeloid blastic phase of chronic myelogenous leukaemia. British Journal of Haematology. 80(3). 310–316. 8 indexed citations
20.
Liso, Vincenzo, et al.. (1990). Continuous Infusion Chemotherapy with Epirubicin and Vincristine in Relapsed and Refractory Acute Leukemia. Acta Haematologica. 83(3). 116–119. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuya Komeno Breakdown of academic impact, for papers by Dina Attias Breakdown of academic impact, for papers by Maurizio Longinotti Breakdown of academic impact, for papers by Gianluigi Castoldi Breakdown of academic impact, for papers by Anastasia Athanasiadou Breakdown of academic impact, for papers by Vassiliki Pappa Breakdown of academic impact, for papers by Mordechai Shtalrid Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Mineo Kurokawa Breakdown of academic impact, for papers by Rose Beck
Rankless by CCL
2026